Sign up to save tools and stay up to date with the latest in AI
bg
bg
1

Mirror, Mirror on the Wall, Are You the Healthiest of All?

Jan 09, 2024 - cnet.com
The Anura MagicMirror, developed by digital health company NuraLogix, is a first-of-its-kind mirror that analyzes facial blood flow to check vitals such as blood pressure and estimate the risk of heart disease. The mirror uses Transdermal Optical Imaging technology to scan the face and send data to the cloud for analysis. The results are displayed as wellness metrics, including metabolic risk assessments for conditions like fatty liver disease and Type 2 diabetes. The company plans to market the mirror in gyms, clinics, and businesses, rather than for home use.

However, the MagicMirror is not a medical device and its measurements should not be taken as a diagnosis. Factors such as makeup, lighting, and the user's ability to sit still could potentially affect the readings. NuraLogix has submitted the technology to the US Food and Drug Administration for clearance over some of its health metrics. The mirror operates similarly to Anura, an app from NuraLogix that uses the same technology and some artificial intelligence under its patented Affective AI technology, DeepAffex.

Key takeaways:

  • The Anura MagicMirror, developed by NuraLogix, is a unique mirror that can analyze blood flow in the face to check vitals like blood pressure and estimate the risk of heart disease.
  • The mirror uses Transdermal Optical Imaging technology to scan the face and provide wellness metrics, including metabolic risk assessments for conditions like fatty liver disease and Type 2 diabetes.
  • While the MagicMirror is not currently marketed for home use, it could soon be seen in gyms, clinics, businesses and other places where people monitor their health.
  • NuraLogix has submitted the MagicMirror's technology to the US Food and Drug Administration for clearance over some of its health metrics, with approval expected for certain heart health and breathing metrics this year.
View Full Article

Comments (0)

Be the first to comment!